Learning Disability Treatment Market by Therapy (Stimulant Medication, Non-Stimulant Medication, Occupational Therapy, Complimentary Therapy, Others) by Indication (Dyslexia, Dyspraxia, Attention Deficit Hyperactivity Disorder (ADHD), Others) by End-User (Hospitals, Clinic, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Published Date: 15-Feb-2021 Category: Technology & Media Report Format : PDF Pages: 110 Report Code: ZMR-5823 Status : Published

The learning disability treatment market is set for a rapid growth over the forecast period. In terms of revenue, the global Learning Disability Treatment market accounted for USD 17.75 Billion in 2019 and is expected to reach USD 28.31 Billion by 2026, growing at a CAGR of 6.90%

Description

The learning disability treatment market is set for a rapid growth over the forecast period. In terms of revenue, the global Learning Disability Treatment market accounted for USD 17.75 Billion in 2019 and is expected to reach USD 28.31 Billion by 2026, growing at a CAGR of 6.90%

Global Learning Disability Treatment Market: Overview

A learning disability is a neurological disorder that affects the capacity of the brain to receive, send, and process information. A person with learning disabilities can have trouble speaking, writing, reading, listening, understanding mathematical concepts, and general understanding. Learning disorders include a category of conditions such as dyspraxia, dyslexia, dysgraphia, dyscalculia and Attention Deficit Hyperactivity Disorder (ADHD). Each form of disorder can co-exist with another.

Learning disabilities are not attributed to low intelligence. In reality, most people with learning disabilities are of average or above-average intelligence, but the influence of disability can affect their ability to perform well in school, at home or at work.

According to research findings of the American Psychiatrist Association (APA), more than 50 per cent of children with learning disorders will never recover from their disabilities. Successful early screening improves the patients’ quality of life with learning disabilities. Government agencies globally are offering sufficient financial resources for the development of new schools and clinics to benefit children and adults struggling from dyslexia, ADHD, dyspraxia and other mental disabilities.

Global Learning Disability Treatment Market: Growth Factors

Researchers are not entirely sure what causes learning disorders. Some of the possibilities include:

Heredity: Learning disorders are also family-run, people with learning disabilities may have parents or other relatives with similar difficulties.

Difficulties during pregnancy and childbirth: Learning disorders could be caused by disease or accident during or before birth. It can also be caused by oxygen deprivation, low birth weight, use of alcohol and drugs during pregnancy, and prolonged or premature labor.

Incidents after birth: Brain injuries, nutritional deprivation and exposure to toxic substances can lead to learning disability development.

Learning disabilities, however, are not caused by economic disadvantages or differences in culture.

All these factors are driving the demand for learning disabilities treatment or therapy. Typical techniques that may assist patient with learning disability include reading out loud, audio messages, color coding organization, the use of graphic organizers (charts, graphs, etc.), and one-on-one school or work training instruction, and the ability to re-state details in one's own words. For adults with learning disabilities, Assistive Technology (AT) is also beneficial at school, work and at home.

Impact due to the outbreak of COVID-19

People with learning disabilities are more likely to be exposed to coronavirus infection, according to a recently released Public Health England survey. These people are at high risk of losing their lives due to the COVID-19 infection because of the lack of care provided to individuals with disabilities. This has created incremental benefits for businesses in the market for learning disability treatment, where organizations can minimize mortality rates by encouraging routine patient testing. In order to minimize exposure to COVID-19, routine staff testing and proper sanitization of their Personal Protective Equipment (PPE) are important.

In addition, adequate funding and provision of services is required for the medical staff and families of people with learning disabilities. Companies in the learning disability treatment sector are boosting their drug development potential, as the healthcare industry is important during the coronavirus pandemic.

Global Learning Disability Treatment Market: Segmentation

The pharmacological therapy constitutes 80 per cent of the treatment recommended by physicians worldwide for the treatment of children with ADHD and cognitive disabilities. Stimulants such as Focalin, Ritalin, etc. are recommended to enhance the activity of the brain Central Nervous System (CNS) by inhibiting the absorption of norepinephrine and dopamine. Non-stimulants are used in patients with signs of depression and anxiety.

Dyslexia is leading the indication category of learning disability treatment market. Nearly 25% of people with ADHD have signs of dyslexia, with a significant difficulty associated with writing, reading and word comprehension difficulties. ADHD is among the most common mental health conditions specifically related to learning disabilities. The high prevalence of ADHD among teenagers and children in Iran creates business opportunities for companies in the learning disability treatment industry. ADHD has a global prevalence rate of 2.2% for males compared to females. Technological innovation of assistive technology in the production of software and applications linked to occupational therapy and Cognitive Behavior Therapy (CBT) are used by teachers across the globe to support children with learning disabilities.

Global Learning Disability Treatment Market: Regional Analysis

By Geography, the learning disability treatment market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America is the largest geographic market for learning disability treatment with a significant market share in 2020. Increased prevalence of ADHD and strict government policies to promote awareness and care for children with learning disabilities are key parameters that affect the market development. Europe held the second largest market share in the year 2020 owing to the growing rate of dyslexia in all age groups.

Asia Pacific is expected to have a highest growth rate in the near future due to the widespread growth of special schools for the treatment of children's learning disorders. Moreover, the major increase in the healthcare companies offering assistive technology coupled with occupational therapy and cognitive behavioral therapy modules is another factor fueling the demand for the market in Asia Pacific.

Global Learning Disability Treatment Market: Competitive Players

The major players in the global learning disability treatment market include Eli Lilly & Company, CogniFit, Pfizer, Inc., Tumble N’ Dots, Inc., IMSE, Shire, Plc., Therapro, Inc., Texthelp Ltd., Forest Laboratories, Inc., and Novartis AG among others.

The report segment of global learning disability treatment market are as follows:

Global Learning Disability Treatment Market: Therapy Segment Analysis

  • Stimulant Medication
  • Non-Stimulant Medication
  • Occupational Therapy
  • Complimentary Therapy
  • Others

Global Learning Disability Treatment Market: Indication Segment Analysis

  • Dyslexia
  • Dyspraxia
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Others

Global Learning Disability Treatment Market: End-User Segment Analysis

  • Hospitals
  • Clinic
  • Others

Global Learning Disability Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Learning Disability Treatment Market, 2016-2026, (USD Billion)
    • 2.2. Learning Disability Treatment Market: Market snapshot
  • Chapter 3. Global Learning Disability Treatment Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Technulogy landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & sustainability
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Learning Disability Treatment Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Therapy Segment
      • 3.11.2. Market Attractiveness Analysis by Indication Segment
      • 3.11.3. Market Attractiveness Analysis by End-User Segment
  • Chapter 4. Global Learning Disability Treatment Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Learning Disability Treatment Market – Therapy Segment Analysis
    • 5.1. Global Learning Disability Treatment Market Revenue Share, by Therapy, 2019 & 2026 (USD Billion)
    • 5.2. Global Learning Disability Treatment Market by Stimulant Medication, 2016 – 2026 (USD Billion)
    • 5.3. Global Learning Disability Treatment Market by Non-Stimulant Medication, 2016 – 2026 (USD Billion)
    • 5.4. Global Learning Disability Treatment Market by Occupational Therapy, 2016 – 2026 (USD Billion)
    • 5.5. Global Learning Disability Treatment Market by Complimentary Therapy, 2016 – 2026 (USD Billion)
    • 5.6. Global Learning Disability Treatment Market by Others, 2016 – 2026 (USD Billion)
  • Chapter 6. Learning Disability Treatment Market – Indication Segment Analysis
    • 6.1. Global Learning Disability Treatment Market Revenue Share, by Indication, 2019 & 2026 (USD Billion)
    • 6.2. Global Learning Disability Treatment Market by Dyslexia, 2016 – 2026 (USD Billion)
    • 6.3. Global Learning Disability Treatment Market by Dyspraxia, 2016 – 2026 (USD Billion)
    • 6.4. Global Learning Disability Treatment Market by Attention Deficit Hyperactivity Disorder (ADHD), 2016 – 2026 (USD Billion)
    • 6.5. Global Learning Disability Treatment Market by Others, 2016 – 2026 (USD Billion)
  • Chapter 7. Learning Disability Treatment Market – End-User Segment Analysis
    • 7.1. Global Learning Disability Treatment Market Revenue Share, by End-User, 2019 & 2026 (USD Billion)
    • 7.2. Global Learning Disability Treatment Market by Hospitals, 2016 – 2026 (USD Billion)
    • 7.3. Global Learning Disability Treatment Market by Clinic, 2016 – 2026 (USD Billion)
    • 7.4. Global Learning Disability Treatment Market by Others, 2016 – 2026 (USD Billion)
  • Chapter 8. Learning Disability Treatment Market - Regional Analysis
    • 8.1. Global Learning Disability Treatment Market: Regional Overview
      • 8.1.1. Global Learning Disability Treatment Market Revenue Share, By Region, 2019 & 2026 (USD Billion)
    • 8.2. North America
      • 8.2.1. North America Learning Disability Treatment Market Revenue 2016 – 2026 (USD Billion)
      • 8.2.2. North America Learning Disability Treatment Market Revenue, By Therapy, 2016 – 2026 (USD Billion)
      • 8.2.3. North America Learning Disability Treatment Market Revenue, By Indication, 2016 – 2026 (USD Billion)
      • 8.2.4. North America Learning Disability Treatment Market Revenue, By End-User, 2016 – 2026 (USD Billion)
      • 8.2.5. U.S.
        • 8.2.5.1. U.S. Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.2.5.2. U.S. Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.2.5.3. U.S. Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.2.6. Canada
        • 8.2.6.1. Canada Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.2.6.2. Canada Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.2.6.3. Canada Education & Learning Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.2.7. Mexico
        • 8.2.7.1. Mexico Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.2.7.2. Mexico Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.2.7.3. Mexico Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
    • 8.3. Europe
      • 8.3.1. Europe Learning Disability Treatment Market Revenue 2016 – 2026 (USD Billion)
      • 8.3.2. Europe Learning Disability Treatment Market Revenue, By Therapy, 2016 – 2026 (USD Billion)
      • 8.3.3. Europe Learning Disability Treatment Market Revenue, By Indication, 2016 – 2026 (USD Billion)
      • 8.3.4. Europe Learning Disability Treatment Market Revenue, By End-User, 2016 – 2026 (USD Billion)
      • 8.3.5. UK
        • 8.3.5.1. UK Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.5.2. UK Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.5.3. UK Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.6. France
        • 8.3.6.1. France Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.6.2. France Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.6.3. France Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.7.2. Germany Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.7.3. Germany Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.8. Italy
        • 8.3.8.1. Italy Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.8.2. Italy Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.8.3. Italy Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.9. Spain
        • 8.3.9.1. Spain Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.9.2. Spain Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.9.3. Spain Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.10. Russia
        • 8.3.10.1. Russia Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.10.2. Russia Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.10.3. Russia Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.3.11. Rest of Europe
        • 8.3.11.1. Rest of Europe Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.3.11.2. Rest of Europe Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.3.11.3. Rest of Europe Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Learning Disability Treatment Market Revenue 2016 – 2026 (USD Billion)
      • 8.4.2. Asia Pacific Learning Disability Treatment Market Revenue, By Therapy, 2016 – 2026 (USD Billion)
      • 8.4.3. Asia Pacific Learning Disability Treatment Market Revenue, By Indication, 2016 – 2026 (USD Billion)
      • 8.4.4. Asia Pacific Learning Disability Treatment Market Revenue, By End-User, 2016 – 2026 (USD Billion)
      • 8.4.5. China
        • 8.4.5.1. China Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.5.2. China Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.5.3. China Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.6.2. Japan Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.6.3. Japan Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.4.7. India
        • 8.4.7.1. India Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.7.2. India Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.7.3. India Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.4.8. Australia
        • 8.4.8.1. Australia Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.8.2. Australia Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.8.3. Australia Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.4.9. South Korea
        • 8.4.9.1. South Korea Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.9.2. South Korea Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.9.3. South Korea Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.4.10. Rest of Asia Pacific
        • 8.4.10.1. Rest of Asia Pacific Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.4.10.2. Rest of Asia Pacific Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.4.10.3. Rest of Asia Pacific Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
    • 8.5. Latin America
      • 8.5.1. Latin America Learning Disability Treatment Market Revenue 2016 – 2026 (USD Billion)
      • 8.5.2. Latin America Learning Disability Treatment Market Revenue, By Therapy, 2016 – 2026 (USD Billion)
      • 8.5.3. Latin America Learning Disability Treatment Market Revenue, By Indication, 2016 – 2026 (USD Billion)
      • 8.5.4. Latin America Learning Disability Treatment Market Revenue, By End-User, 2016 – 2026 (USD Billion)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.5.5.2. Brazil Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.5.5.3. Brazil Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.5.6. Argentina
        • 8.5.6.1. Argentina Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.5.6.2. Argentina Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.5.6.3. Argentina Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.5.7. Rest of Latin America
        • 8.5.7.1. Rest of Latin America Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.5.7.2. Rest of Latin America Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.5.7.3. Rest of Latin America Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Learning Disability Treatment Market Revenue 2016 – 2026 (USD Billion)
      • 8.6.2. Middle East & Africa Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
      • 8.6.3. Middle East & Africa Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
      • 8.6.4. Middle East & Africa Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.6.5. GCC Countries
        • 8.6.5.1. GCC Countries Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.6.5.2. GCC Countries Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.6.5.3. GCC Countries Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.6.6. South Africa
        • 8.6.6.1. South Africa Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.6.6.2. South Africa Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.6.6.3. South Africa Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
      • 8.6.7. Rest of MEA
        • 8.6.7.1. Rest of MEA Learning Disability Treatment Market Revenue, by Therapy, 2016 – 2026 (USD Billion)
        • 8.6.7.2. Rest of MEA Learning Disability Treatment Market Revenue, by Indication, 2016 – 2026 (USD Billion)
        • 8.6.7.3. Rest of MEA Learning Disability Treatment Market Revenue, by End-User, 2016 – 2026 (USD Billion)
  • Chapter 9. Company Profiles
    • 9.1. Eli Lilly & Company
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfulio
      • 9.1.4. Business strategy
      • 9.1.5. Recent developments
    • 9.2. *Same information will be provided for below mentioned companies*
      • 9.2.1. CogniFit
      • 9.2.2. Pfizer, Inc.
      • 9.2.3. Tumble N’ Dots, Inc.
      • 9.2.4. IMSE
      • 9.2.5. Shire, Plc.
      • 9.2.6. Therapro, Inc.
      • 9.2.7. Texthelp Ltd.
      • 9.2.8. Forest Laboratories, Inc.
      • 9.2.9. Novartis AG
      • 9.2.10. Others

Methodology


Frequently Asked Questions

Researchers are not entirely sure what causes learning disorders. Some of the possibilities include:

Heredity: Learning disorders are also family-run, people with learning disabilities may have parents or other relatives with similar difficulties.

Difficulties during pregnancy and childbirth: Learning disorders could be caused by disease or accident during or before birth. It can also be caused by oxygen deprivation, low birth weight, use of alcohol and drugs during pregnancy, and prolonged or premature labor.

Incidents after birth: Brain injuries, nutritional deprivation and exposure to toxic substances can lead to learning disability development.

Learning disabilities, however, are not caused by economic disadvantages or differences in culture.

All these factors are driving the demand for learning disabilities treatment or therapy. Typical techniques that may assist patient with learning disability include reading out loud, audio messages, color coding organization, the use of graphic organizers (charts, graphs, etc.), and one-on-one school or work training instruction, and the ability to re-state details in one's own words. For adults with learning disabilities, Assistive Technology (AT) is also beneficial at school, work and at home.

According to Zion Market Research, the Learning Disability Treatment market is expected to generate revenue of around USD 28.31 Billion by the end of 2026, growing at a CAGR of 6.90%.

By Geography, the learning disability treatment market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

North America is the largest geographic market for learning disability treatment with a significant market share in 2020. Increased prevalence of ADHD and strict government policies to promote awareness and care for children with learning disabilities are key parameters that affect the market development. Europe held the second largest market share in the year 2020 owing to the growing rate of dyslexia in all age groups.

Asia Pacific is expected to have a highest growth rate in the near future due to the widespread growth of special schools for the treatment of children's learning disorders. Moreover, the major increase in the healthcare companies offering assistive technology coupled with occupational therapy and cognitive behavioral therapy modules is another factor fueling the demand for the market in Asia Pacific.

The major players in the global learning disability treatment market include Eli Lilly & Company, CogniFit, Pfizer, Inc., Tumble N’ Dots, Inc., IMSE, Shire, Plc., Therapro, Inc., Texthelp Ltd., Forest Laboratories, Inc., and Novartis AG among others.

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Accept

We have secured system to process your transaction.


We Are On Social